A federally funded research team led by Sheri Holmen, PhD, investigator at Huntsman Cancer Institute and professor in the Department of Surgery at the University of Utah (the U), is testing a new ...
Researchers with the University of Cincinnati and Johns Hopkins Medicine developed a potential treatment for brain cancer ...
NDA acceptance with Priority Review builds upon previous assignment of Breakthrough Therapy Designation and Real-Time Oncology Review following ...
Morning Overview on MSN
A drug combo studied for anti-aging just backfired in mice — researchers caught severe loss of the brain’s insulation, mimicking the 'chemo brain' it was meant to fight
A pair of drugs celebrated in anti-aging circles for clearing worn-out cells from the body has now been caught doing ...
Researchers developed a potential treatment for brain cancer that uses nanofibers embedded with a combination of drugs that ...
A combination drug treatment doubled survival time for patients with an aggressive form of colorectal cancer, according to late-stage trial data published Friday in The New England Journal of Medicine ...
In patients with an aggressive form of breast cancer, treatment with the antibody-drug conjugate sacituzumab govitecan plus pembrolizumab resulted in durable responses with improved progression free ...
A research team at Oregon Health & Science University has discovered a promising new drug combination that may help people with acute myeloid leukemia overcome resistance to one of the most common ...
A new study suggests a single ketamine infusion followed by low-dose buprenorphine significantly sustained reductions in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results